XML 81 R65.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue - Revenue by Type (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2023
Sep. 24, 2022
Sep. 25, 2021
Disaggregation of Revenue [Line Items]      
Revenues $ 4,030.4 $ 4,862.8 $ 5,632.3
Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 1,880.1 3,018.5 3,695.0
United States      
Disaggregation of Revenue [Line Items]      
Revenues 3,058.0 3,467.9 3,902.3
United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 1,396.2 2,027.3 2,393.1
International      
Disaggregation of Revenue [Line Items]      
Revenues 972.4 1,394.9 1,730.0
International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 483.9 991.2 1,301.9
Consumables      
Disaggregation of Revenue [Line Items]      
Revenues 2,539.4 3,603.6 4,198.2
Capital equipment, components and software      
Disaggregation of Revenue [Line Items]      
Revenues 740.5 587.6 769.1
Service      
Disaggregation of Revenue [Line Items]      
Revenues 730.5 652.4 598.1
Other      
Disaggregation of Revenue [Line Items]      
Revenues 20.0 19.2 66.9
Cytology & Perinatal | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 480.6 474.7 473.9
Cytology & Perinatal | United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 297.4 300.4 304.6
Cytology & Perinatal | International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 183.2 174.3 169.3
Molecular Diagnostics | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 1,361.7 2,511.4 3,171.5
Molecular Diagnostics | United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 1,061.0 1,694.5 2,038.9
Molecular Diagnostics | International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 300.7 816.9 1,132.6
Blood screening [Member] | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 37.8 32.4 49.6
Blood screening [Member] | United States | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues 37.8 32.4 49.6
Blood screening [Member] | International | Diagnostics      
Disaggregation of Revenue [Line Items]      
Revenues $ 0.0 $ 0.0 $ 0.0